In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Pharma and Biopharma is a trillion-dollar industry providing ample career opportunities for laboratory scientists and entrepreneurs. Join Principal Consultant Michael W. Dong of MWD Consulting as he ...

invoX Pharma Limited (“invoX”), a research-driven global biopharmaceutical company with an advancing pipeline of innovative products, and Insilico Medicine (“Insilico”), a leading and global clinical ...

The "An Essential Overview of the Pharmaceutical and Biotech Industries (Sept 28, 2026)" has been added to ResearchAndMarkets.com's offering. This one-day intensive course provides a structured and ...

Around 1990, a bright, young Harvard academic became interested in the possibility that a relatively unknown peptide might slow gastric emptying and reduce hunger — a potential boon to the treatment ...

What are the top ten companies that academics go to when taking a research position in the private sector? There are a lot to choose from. The world of commercial research and development (R&D) spans ...

Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology. The last two years have witnessed explosive growth in the implementation ...

Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...